One of the most significant risks transfusion patients face is an adverse reaction to blood products such as whole blood, red blood cells (RBC), platelets, and plasma. A number of factors can trigger an adverse reaction, but the most prevalent cause is RBC product incompatibility. Every year blood product transfusions benefit millions of patients, but…

Read More

Just when we thought our Annual Retreat couldn’t look any different (read about last year’s virtual retreat here), we introduced the first hybrid retreat, an in-person and virtual congregation of employees. One group of Lantanians traveled back to Tucson to our beloved Tanque Verde Ranch, while the rest convened virtually via Microsoft Teams, joining the…

Read More

In 2019, the Centers for Disease Control and Prevention developed neonatal-specific (Standardized Antimicrobial Administration Ratios SAARs), a set of risk-adjusted antimicrobial use metrics that hospitals participating in the National Healthcare Safety Network’s (NHSN’s) antimicrobial use surveillance can use in their antibiotic stewardship programs (ASPs). This article outlines the methods and results of developing those SAARs.…

Read More

The Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN) surveillance system and Yale New Haven Health (YNHHS)/Yale Center for Medical Informatics today announced that they are collaborating on a project to demonstrate implementation readiness for end-to-end automation of hospital pandemic reporting from the Yale-New Haven Health to NHSN.

Read More

Following our annual retreat in November 2019, Lantana created the Diversity and Inclusion Group (DIG) to promote policy changes and encourage diversity and inclusion company wide. We came up with the idea for the DIG during the retreat gallery walk session on the topic of Community. This discussion sparked interest in a focused effort on…

Read More

The Centers for Medicare and Medicaid Services (CMS) collects data from hospitals and other healthcare facilities nationwide which results in a good problem—a wealth of information without an effective way to use it to assess quality at the hospital level. The state of Maryland had publicly reported data which they need to consolidate for a…

Read More

The Standardized Antimicrobial Administration Ratio (SAAR) is a risk-adjusted metric of antimicrobial use (AU) developed by the Centers for Disease Control and Prevention (CDC) in 2015 as a tool for hospital antimicrobial stewardship programs (ASPs) to track and compare AU with a national benchmark. In 2018, CDC updated the SAAR by expanding the locations and…

Read More